HTG Molecular Diagnostics Interest Expense 2011-2026 | HTGM

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense HTG Molecular Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
857 K	1.06 M	1.02 M	958 K	902 K	1.31 M	1.87 M	1.72 M	707 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.87 M	707 K	1.16 M

Quarterly Interest Expense HTG Molecular Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	200 K	239 K	249 K	-	267 K	260 K	270 K	-	273 K	251 K	225 K	-	242 K	239 K	234 K	-	234 K	233 K	183 K	-	300 K	350 K	398 K	-	491 K	539 K	392 K	-	379 K	476 K	479 K	-	161 K	56.4 K	74.5 K	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
539 K	56.4 K	285 K

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	81 M	$ 115.62	0.06 %	$ 35.1 B	USA
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Illumina ILMN	-292 M	$ 128.52	0.5 %	$ 20.4 B	USA
Accelerate Diagnostics AXDX	235 K	-	-61.36 %	$ 2.46 M	USA
Co-Diagnostics CODX	106 K	$ 1.65	-1.2 %	$ 2.19 M	USA
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Lantheus Holdings LNTH	31.3 M	$ 84.11	-0.26 %	$ 5.68 B	USA
Medpace Holdings MEDP	-5.34 M	$ 421.37	2.64 %	$ 12.2 B	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	1 K	$ 24.98	2.13 %	$ 694 M	USA
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Koninklijke Philips N.V. PHG	288 M	$ 27.54	0.25 %	$ 20 B	Niderland
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
Personalis PSNL	24 K	$ 5.96	-2.3 %	$ 353 M	USA
CareDx, Inc CDNA	524 K	$ 21.85	2.92 %	$ 1.16 B	USA
Senseonics Holdings SENS	-23 K	$ 7.27	3.12 %	$ 303 M	USA
Soleno Therapeutics SLNO	110 K	$ 52.75	0.06 %	$ 2.68 B	USA
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	561 K	$ 15.6	-4.35 %	$ 472 M	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Thermo Fisher Scientific TMO	-12 M	$ 468.04	-0.36 %	$ 176 B	USA
Genetic Technologies Limited GENE	15.2 K	-	-	$ 7.1 B	Australia
Trinity Biotech plc TRIB	6.75 M	$ 0.64	-0.82 %	$ 61.9 M	Irlanda
Charles River Laboratories International CRL	-22.6 M	$ 171.23	0.86 %	$ 8.49 B	USA
Twist Bioscience Corporation TWST	-903 K	$ 61.0	0.1 %	$ 3.65 B	USA
Guardant Health GH	-10.5 M	$ 88.5	-0.46 %	$ 11.1 B	USA
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	-252 K	-	-	$ 8.54 M	USA
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
QIAGEN N.V. QGEN	-6.65 M	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	38.1 M	$ 9.45	-0.94 %	$ 2.05 B	USA
Biomerica BMRA	367	$ 2.18	1.87 %	$ 5.01 M	USA
National Research Corporation NRC	-95 K	$ 17.11	-0.7 %	$ 383 M	USA
ICON Public Limited Company ICLR	337 M	$ 103.21	1.02 %	$ 8.51 B	Irlanda
Laboratory Corporation of America Holdings LH	224 M	$ 263.43	-0.14 %	$ 21.9 B	USA
Celcuity CELC	2.11 M	$ 125.68	3.84 %	$ 5.88 B	USA
OpGen OPGN	7.56 K	-	-16.95 %	$ 1.54 M	USA
NeoGenomics NEO	296 K	$ 8.61	3.86 %	$ 1.1 B	USA
Myriad Genetics MYGN	800 K	$ 4.83	1.05 %	$ 447 M	USA
Natera NTRA	9.32 M	$ 204.46	0.35 %	$ 20.1 B	USA
Quest Diagnostics Incorporated DGX	26 M	$ 196.63	0.18 %	$ 21.8 B	USA
Invitae Corporation NVTA	56.7 M	-	-	$ 21.2 M	USA